Multivitamins have traditionally been organised around age, gender and life stage.
There are formulas for children, women, men, pregnancy, menopause and healthy ageing.
Now the supplement industry has created a new consumer identity:
The person taking a GLP-1 medication.
Products such as Nature Made GLP-1 Companion Health Pack and The Vitamin Shoppe Whole Health Rx GLP-1 Support Multivitamins are designed specifically for consumers using medicines including Ozempic, Wegovy, Mounjaro and Zepbound.
These formulas sit inside a wider system of GLP-1 companion products containing protein, fibre, probiotics, electrolytes and digestive-support ingredients.
The proposition is straightforward:
When medication causes someone to eat substantially less, every meal—and every supplement—must work harder nutritionally.
This is one signal from the Consensys Innovation Signals Engine, which continuously scans a library of more than one million products worldwide for emerging shifts in formulation, positioning and consumer demand.
Signal: Medication-Companion Nutrition
The drugs created a nutritional occasion
GLP-1 receptor agonists were developed for diabetes and are now widely used in obesity treatment.
The medicines can reduce appetite, increase feelings of fullness and slow gastric emptying. For many users, this leads to much smaller meals and significant weight loss.
That creates a nutritional challenge.
A person who consumes less food may also consume less:
- Protein
- Fibre
- Calcium
- Vitamin D
- Vitamin B12
- Iron
- Magnesium
- Other vitamins and minerals
The medication does not necessarily remove these nutrients from the body directly. The risk often comes from reduced overall food intake, food aversions, gastrointestinal side effects or an increasingly restrictive diet.
A 2025 clinical advisory on nutrition during GLP-1 therapy highlighted the importance of nutrient-dense foods, adequate protein, resistance exercise and monitoring for nutritional inadequacy during treatment.
Consumer Need: More Nutrition in Less Food
The category did not suddenly appear in 2025
The original the original finding describes GLP-1 companion nutrition as a 2025-created category.
Its development began slightly earlier.
In April 2024, GNC launched a GLP-1 support programme covering nutritional gaps, gastrointestinal health, muscle preservation and bone support.
The market became much more recognisable in 2025.
In March 2025, The Vitamin Shoppe introduced a dedicated GLP-1 Support line under its Whole Health Rx brand. The range covered five distinct territories:
- Multivitamins
- Protein
- Fibre
- Synbiotics
- An all-in-one nutrient powder
By 2026, The Vitamin Shoppe's wider online GLP-1 nutrition section contained dozens of products across these categories.
Category Emergence: 2024Rapid Brand Expansion: 2025–2026Category Structure: Vitamins plus protein, fibre and digestive support
Nature Made turned the category into a daily packet
One of the clearest flagship products is the Nature Made GLP-1 Companion Health Pack.
Each daily packet contains four separate supplements:
- A multivitamin
- Magnesium
- Vitamin B12
- Vitamin D3 with calcium
Together, the packet provides 22 nutrients. Nature Made positions it as nutritional support for people following weight-loss diets, including those taking GLP-1 medications.
Product: Nature Made GLP-1 Companion Health Pack
Brand: Nature Made
Manufacturer: Pharmavite
Format: Four-in-one daily supplement packet
Consumer Promise: Convenient support for potential nutrient gaps during weight loss
The innovation is not primarily a newly discovered ingredient.
Most components are familiar supplements already sold individually.
The innovation is regimen architecture: identifying a medication-linked consumer need and packaging several established products into one daily routine.
Innovation Type: Condition-Specific Supplement Bundling
The Vitamin Shoppe built an entire product system
The Vitamin Shoppe took a broader approach.
Its Whole Health Rx GLP-1 Support collection was developed around the different problems users may face during medication-assisted weight loss.
GLP-1 Support Multivitamins
Separate men's and women's formulas provide broad vitamin and mineral support. They also contain Suntheanine, a branded form of L-theanine, and ginger, which the retailer associates with stress support and occasional nausea.
GLP-1 Support Protein
The formula contains 30 grams of whey protein, five grams of collagen and branded ingredients including myHMB and PeptiStrong, positioned around muscle preservation.
GLP-1 Support Fibre
This contains 15 grams of fibre per serving and is intended to support digestive regularity.
GLP-1 Support Synbiotic
The product combines a prebiotic, probiotic and postbiotic system.
GLP-1 Support Nutrient Powder
The all-in-one powder supplies 25 grams of protein, fibre, digestive enzymes and 24 vitamins and minerals.
Innovation Type: Medication-Companion Product Ecosystem
Instead of selling one GLP-1 multivitamin, the retailer has created a complete shelf organised around a pharmaceutical treatment journey.
Muscle preservation may be the category's strongest need
The most important GLP-1 nutrition issue may not be vitamins.
It may be muscle.
Significant weight loss normally includes some loss of lean mass as well as body fat. Researchers and clinicians are examining how much muscle is lost during GLP-1 treatment and how this varies according to diet, activity, age and the speed of weight reduction.
Clinical nutrition guidance emphasises adequate protein intake and resistance exercise as important tools for preserving muscle during weight loss.
This explains why GLP-1 companion shelves are not dominated exclusively by conventional multivitamins.
They contain:
- High-protein powders
- Ready-to-drink protein products
- Essential amino acids
- HMB-containing products
- Collagen
- Creatine
- Strength and exercise programmes
- Innovation Territory: Lean-Mass Preservation
A multivitamin can help fill certain micronutrient gaps.
It cannot replace adequate protein or resistance training.
Fibre addresses a different problem
Constipation is a commonly reported issue among people using GLP-1 medications.
The medicines slow digestion, while reduced food intake can mean users consume less fibre and fluid.
This has created demand for:
- Soluble fibre
- Prebiotic fibre
- Probiotics
- Synbiotics
- Hydration products
- Electrolytes
Ingredient supplier FrieslandCampina Ingredients identified GLP-1 companion products as a significant new nutraceutical opportunity in 2025, emphasising protein, fibre and micronutrient density as consumers eat smaller portions.
The category is therefore addressing two different objectives:
- Replace what reduced eating may remove
- and
- Manage side effects that make eating difficult
- Not everyone taking a GLP-1 needs a multivitamin
This is the most important limitation.
Using a GLP-1 medication does not automatically mean a person is deficient in vitamins or minerals.
A consumer who continues eating a varied, nutrient-dense diet may not require a dedicated supplement. A person with restricted intake, persistent vomiting or a diagnosed deficiency may need more targeted support than a standard multivitamin provides.
GoodRx's clinical guidance notes that a daily multivitamin is not routinely required simply because someone takes a GLP-1 medicine, although it may be considered when dietary intake is restrictive.
Emerging research has found higher recorded rates of nutritional deficiencies among some adults using GLP-1 receptor agonists, but these observational findings do not prove that the medication directly caused every deficiency. Existing diet quality, diabetes, obesity and other health conditions may also contribute.
Evidence Signal: Individual Need Varies
"GLP-1 friendly" is not a regulated nutritional standard
Food and supplement brands increasingly use language such as:
- GLP-1 friendly
- GLP-1 support
- GLP-1 companion
- Ozempic support
- Metabolic support
These phrases can make products appear medically specialised.
However, "GLP-1 friendly" is not a standardised FDA or USDA certification. It does not guarantee a specific protein level, nutrient profile or clinical benefit.
Dietitians have warned that products carrying the term can still be high in sodium, saturated fat or other ingredients consumers may wish to limit.
For supplements, the naming can also blur the boundary between:
- Supporting nutrition during treatment
- and
- Improving the drug's medical effect
The products are not substitutes for prescribed medication, clinical monitoring or a balanced diet.
Risk Signal: Medicalised Marketing Without a Formal Standard
The formula must avoid creating a second problem
Consumers taking GLP-1 medicines may already use several supplements.
A new companion pack could lead them to duplicate:
- Vitamin D
- Calcium
- Magnesium
- Vitamin B12
- Iron
- Zinc
- Other nutrients
Some ingredients can also interact with medications or be inappropriate at high doses for people with certain health conditions.
A four-product daily packet looks simple, but it may add complexity when combined with the consumer's existing regimen.
The strongest GLP-1 companion brands will need to provide:
- Complete dosage transparency
- Warnings about nutrient duplication
- Clear guidance on who may not need the product
- Separate formulas for different dietary needs
- Advice to consult a clinician or dietitian
- Evidence supporting any specialised ingredients
- Trust Mechanism: Regimen-Level Transparency
- The category is expanding beyond supplements
Major food companies are developing products for the same consumer.
Nestlé Vital Pursuit offers portion-controlled frozen meals with protein and fibre. Other companies have developed high-protein meals, shakes and snacks aimed at people eating smaller portions.
By 2026, Nestlé was also studying how GLP-1 medicines may affect taste and appetite, including whether users prefer stronger seasoning and smaller portions.
Danone North America has published GLP-1 nutrition guidance centred on protein-rich foods and resistance exercise.
This is turning GLP-1 companion nutrition into a cross-category innovation platform covering:
- Multivitamins
- Protein supplements
- Fibre supplements
- Frozen meals
- Snack bars
- Hydration
- Gut health
- Muscle support
- Post-medication weight maintenance
- Market Signal: Pharmaceutical-Led Food Innovation
- The consumer journey may continue after the medication stops
The first generation of products focuses on people actively taking GLP-1 drugs.
The next growth opportunity may be post-GLP-1 nutrition.
Some consumers discontinue treatment because of cost, side effects, supply or personal choice. They may then seek support with:
- Appetite management
- Weight maintenance
- Muscle rebuilding
- Digestive health
- Higher-protein eating
- Behavioural transition
Ingredient and supplement companies are already discussing companion products for both active treatment and the post-medication period.
This could turn a temporary medication-related purchase into a much longer consumer lifecycle.
Innovation Territory: Post-GLP-1 Transition Support
A pharmaceutical brand name has become a consumer category
The phrase "the Ozempic economy" is often used to describe how weight-loss medication affects restaurants, clothing, fitness and food sales.
The supplement category shows the mechanism particularly clearly.
GLP-1 drugs have created:
- A new consumer segment
- A new nutritional occasion
- New retail shelves
- New product bundles
- New claims
- New clinical-evidence questions
The active ingredients inside the multivitamin may not be revolutionary.
The targeting is.
Before GLP-1 medicines became widely used for weight management, few consumers entered a store looking for a multivitamin designed around their injection.
Now major retailers and one of America's largest vitamin brands sell exactly that.
The category's future depends on personalisation
A generic GLP-1 multivitamin assumes that users share the same needs.
They do not.
Nutritional requirements vary according to:
- Age
- Sex
- Starting diet
- Medication and dose
- Speed of weight loss
- Gastrointestinal side effects
- Existing deficiencies
- Medical conditions
- Exercise
- Life stage
The most scientifically credible future model may combine:
- Dietary assessment
- Blood testing where appropriate
- Medication and symptom review
- Protein and fibre targets
- Personalised supplementation
- Ongoing monitoring
That would move the category from GLP-1-labelled products toward GLP-1-responsive nutrition.
Innovation Type: Personalised Medication-Companion Nutrition
This is a genuine new category—but not a universal prescription
The GLP-1 companion market is real.
GNC established an early support programme in 2024.
The Vitamin Shoppe created a complete dedicated range in 2025.
Nature Made now sells a daily pack explicitly positioned as a GLP-1 companion.
The products reflect genuine concerns involving reduced food intake, muscle loss, constipation and nutritional adequacy.
But the category's credibility will depend on resisting a simple marketing shortcut:
Taking a GLP-1 does not automatically create the same deficiency in every person.
The strongest products will help consumers obtain the nutrients they actually need.
The weakest will place familiar vitamins in a new box and allow the name of a blockbuster GLP-1 drug to do the rest.
Brand Radar Signal Tags
Brands and Organisations
Nature MadePharmaviteThe Vitamin ShoppeWhole Health RxGNCNestléVital PursuitDanone North AmericaFrieslandCampina Ingredients
Medications and Pharmaceutical Brands
OzempicWegovyMounjaroZepboundSemaglutideTirzepatideGLP-1 Receptor Agonists
Products
Nature Made GLP-1 Companion Health PackWhole Health Rx GLP-1 Support MultivitaminsWhole Health Rx GLP-1 Support ProteinWhole Health Rx GLP-1 Support FibreWhole Health Rx GLP-1 Support SynbioticWhole Health Rx GLP-1 Support Nutrient PowderNestlé Vital Pursuit
Innovation Types
Medication-Companion NutritionCondition-Specific MultivitaminGLP-1 Nutritional SupportCondition-Specific Supplement BundlingMedication-Companion Product EcosystemLean-Mass PreservationDigestive-Support NutritionPost-GLP-1 Transition SupportPersonalised Medication-Companion NutritionPharmaceutical-Led Food Innovation
Ingredients and Technologies
ProteinFibreMagnesiumVitamin B12Vitamin D3CalciumMultivitaminsProbioticsPrebioticsPostbioticsHMBL-TheanineGingerElectrolytes
Consumer Needs
Fill Potential Nutrient GapsPreserve Lean MuscleSupport Digestive RegularityMaintain Bone HealthSupport Reduced Food IntakeManage Smaller PortionsConvenient Daily RegimenWeight-Maintenance Support
Market Signals
Ozempic EconomyNew Supplement Sub-CategoryGLP-1 Companion ProductsMedicalised WellnessReduced-Appetite NutritionProtein-and-Fibre InnovationRetail-Shelf ReorganisationCondition-Led PremiumisationCross-Category GLP-1 Innovation
Risk and Evidence Signals
Not Universally RequiredIndividual Nutritional Needs VaryGLP-1 Friendly Is Not a Regulated StandardNutrient Duplication RiskMedicalised MarketingReduced Intake Versus Direct Drug EffectProduct-Specific Clinical Evidence GapSupplement-Medication InteractionProfessional Guidance Recommended
Sources
Official product and retailer sources
Nature Made — GLP-1 Companion Health Pack: Four daily supplements providing 22 nutrients for people following weight-loss diets, including GLP-1 users. https://www.naturemade.com/products/glp-1-companion-health-pack
Nature Made — GLP-1 Nutritional Support Collection: Product positioning and benefit structure.
The Vitamin Shoppe — Whole Health Rx GLP-1 Support launch: Full five-product range, formulas and company positioning. https://press.vitaminshoppe.com/2025-03-31-the-vitamin-shoppe-unveils-first-of-its-kind-supplement-line-formulated-for-glp-1-users/
The Vitamin Shoppe — GLP-1 Nutrient Support category: Current products across multivitamins, protein, probiotics and fibre.
Clinical and nutritional evidence
American Journal of Clinical Nutrition — Nutritional priorities during GLP-1 therapy: Clinical guidance covering protein, muscle, micronutrients and dietary quality.
GoodRx — Supplements used with GLP-1 medicines: Notes that a multivitamin is not routinely required for every user.
Obesity Pillars — Nutritional deficiencies and muscle loss among adults using GLP-1 medicines: Observational evidence of increased recorded nutritional deficiencies.
Dietary supplement considerations during GLP-1 therapy: Review of potential benefits, limitations and safety considerations.
Market and industry sources
GNC's early GLP-1 support programme: Industry reporting dates its launch to April 2024.
FrieslandCampina Ingredients — GLP-1 companion opportunity: Protein, fibre and nutrient-density innovation.
NutritionInsight — Companion and post-medication products: Industry development in 2026.
Associated Press — "GLP-1 friendly" food marketing: The term is not a regulated FDA or USDA nutritional standard.
Danone North America — GLP-1 nutrition support: Protein-rich foods and resistance exercise for preserving muscle.